查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428163

2024 年静脉 (IV) 水化疗法全球市场报告

Intravenous (IV) Hydration Therapy Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

静脉（IV）水化疗法市场规模预计在未来几年将显着成长。预计到 2028 年将以 8.8% 的复合年增长率 (CAGR) 增长至 39.2 亿美元。预测期内的预期增长是由静脉补水疗法转向以消费者为中心的个人化、将其融入企业健康计划、更加重视预防性健康措施以及健身和健康旅游领域的扩张所推动的。这是多种因素造成的，其中包括人口老化导致的需求增加。在此期间预计的主要趋势包括道德和永续采购惯例、结合静脉水化疗法的整体健康静修的出现，以及建立水化酒吧和休息室以满足健康需求；其中包括更加关注与水化疗法相结合的心理健康服务。这些趋势将在预测期内对市场产生重大影响并塑造其轨迹。

慢性病盛行率的快速成长预计将推动静脉（IV）水化治疗市场的显着成长。这种治疗方法包括静脉注射维生素和必需营养素，为对抗慢性疾病的个体提供显着的能量提升。截至 2022 年 9 月，世界卫生组织报告称，每年有 4,100 万人死亡，占全球非传染性疾病 (NCD) 或慢性病死亡人数的 74%。其中，1,790万人死于心血管疾病，930万人死于癌症，410万人死于慢性呼吸道疾病，200万人死于糖尿病。这种慢性疾病盛行率的上升是推动静脉（IV）水化治疗市场成长的关键因素。

老龄化人口的持续成长预计将进一步推动静脉（IV）水化治疗市场的扩张。人口老化的特征是社会中老年人比例不断增加，静脉补水疗法可以有效解决这一问题，该疗法可以对抗脱水并提供必需的营养，从而促进整体健康和福祉。世界卫生组织 2022 年 10 月发布的预测显示，到 2030 年，全球六分之一的人口将超过 60 岁。在此期间，60岁及以上人口的比例预计将从2020年的10亿增加到14亿。此外，到 2050 年，全球 60 岁及以上人口预计将增加一倍，达到 21 亿。因此，人口老化的加剧是静脉（IV）水化治疗市场的关键驱动因素。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球静脉 (IV) 水化治疗市场驱动因素与限制
    • 市场驱动力
    • 市场限制
  • 2018-2023 年全球静脉 (IV) 水化治疗市场规模、表现和成长
  • 全球静脉 (IV) 水化治疗市场规模及成长预测，2023-2028 年、2033 年

第六章市场区隔

  • 全球静脉 (IV) 水化治疗市场，按服务、绩效和预测细分，2018-2023、2023-2028、2033
  • 免疫增强剂
  • 能量助推器
  • 护肤
  • 偏头痛
  • 其他服务
  • 全球静脉 (IV) 水化治疗市场，按成分、表现和预测细分，2018-2023、2023-2028、2033
  • 药用
  • 非药用的
  • 全球静脉 (IV) 水化治疗市场，按最终用户细分、绩效和预测，2018-2023、2023-2028、2033
  • 医院和诊所
  • 健康中心和水疗中心
  • 家庭治疗
  • 其他最终用户

第 7 章 区域与国家分析

  • 全球静脉 (IV) 水化治疗市场，按地区、绩效和预测，2018-2023、2023-2028、2033
  • 全球静脉 (IV) 水化治疗市场，按国家、绩效和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 静脉（IV）水化治疗市场的竞争形势
  • 静脉（IV）水化治疗市场公司概况
    • Revitalist
    • JW Life Science Corporation
    • NextGen Healthcare
    • B. Braun Medical Inc.
    • Pfizer Inc.

第31章 其他大型创新公司

  • Fresenius Kabi AG
  • Liquid IV
  • Medtronic Plc.
  • Drip Hydration
  • Amanta Healthcare Ltd.
  • Becton Dickinson and Company
  • Elixir
  • Baxter International Inc.
  • Otsuka Pharmaceutical Co. Ltd.
  • Sippex IV bag
  • REVIV
  • Braun Melsungen AG
  • The IV Doc Inc.
  • Terumo Medical Corporation
  • Grifols SA

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14007

Intravenous (IV) hydration therapy is a simple medical procedure involving the insertion of a small IV into the arm to deliver fluids directly into the bloodstream. This method facilitates faster absorption of nutrients, fluids, medications, and blood, aiding in the body's treatment and recovery process by utilizing the circulatory system.

The primary service categories within intravenous (IV) hydration therapy encompass immune boosters, energy boosters, skin care treatments, migraine relief, and other specialized therapies. Immunity boosters are products designed to enhance the immune system and reduce susceptibility to illnesses. These products come in medicated and non-medicated forms and cater to diverse end-users, including hospitals and clinics, wellness centers and spas, home healthcare services, and other relevant facilities.

The intravenous(IV) hydration therapy market research report is one of a series of new reports from The Business Research Company that provides intravenous(IV) hydration therapy market statistics, including intravenous(IV) hydration therapy industry global market size, regional shares, competitors with an intravenous(IV) hydration therapy market share, detailed intravenous(IV) hydration therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the intravenous(IV) hydration therapy industry. This intravenous (IV) hydration therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intravenous (iv) hydration therapy market size has grown strongly in recent years. It will grow from $2.57 billion in 2023 to $2.8 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth observed in the historical period can be attributed to several factors including advancements in medical treatments and procedures, the use of intravenous (IV) hydration therapy for enhancing athletic and sports performance, clinical management of dehydration in various health conditions, aiding in recovery from illnesses, and the emergence of mobile and concierge services offering this therapy. These factors collectively contributed to the expansion of the IV hydration therapy market during the historic period.

The intravenous (iv) hydration therapy market size is expected to see strong growth in the next few years. It will grow to $3.92 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The anticipated growth in the forecast period is expected to stem from various factors, including a shift towards consumer-centric personalization of IV hydration therapy, its integration into corporate wellness programs, increased emphasis on preventive health measures, expansion within the fitness and wellness tourism sectors, and heightened demand driven by an aging population. Key trends projected for this period encompass ethical and sustainable sourcing practices, the emergence of holistic health retreats incorporating IV hydration therapy, the establishment of hydration bars and lounges catering to wellness needs, and a growing focus on mental wellness in conjunction with hydration therapy services. These trends are poised to significantly impact the market and shape its trajectory in the forecasted period.

The anticipated surge in the prevalence of chronic diseases is poised to drive significant growth in the intravenous (IV) hydration therapy market. This therapeutic approach involves the administration of vitamins and essential nutrients intravenously, offering a substantial energy boost to individuals grappling with chronic diseases. As of September 2022, the World Health Organization reported a staggering 41 million annual deaths, accounting for 74% of fatalities attributed to non-communicable diseases (NCDs) or chronic ailments globally. Notably, cardiovascular diseases contributed to 17.9 million deaths, cancer to 9.3 million deaths, chronic respiratory diseases to 4.1 million deaths, and diabetes to 2.0 million deaths. This escalation in chronic disease prevalence is a pivotal factor propelling the growth of the intravenous (IV) hydration therapy market.

The continual rise in the aging population is poised to further fuel the expansion of the intravenous (IV) hydration therapy market. Characterized by an increasing proportion of elderly individuals in society, the aging population is effectively addressed by IV hydration therapy to combat dehydration and provide essential nutrients, thereby enhancing overall health and well-being. Projections from the World Health Organization in October 2022 indicated that, by 2030, one out of every six individuals globally would be 60 years old or older. The proportion of the population aged 60 and over is expected to rise from 1 billion in 2020 to 1.4 billion during this period. Furthermore, the global population of individuals aged 60 and older is anticipated to double, reaching 2.1 billion by 2050. Consequently, the increasing aging population stands as a significant driver for the intravenous (IV) hydration therapy market.

The intravenous (IV) hydration therapy market is experiencing a notable trend towards product innovation, with major companies leveraging new technologies to maintain their market positions. An illustrative example occurred in September 2022 when Concierge Medical Consultants Inc, a Canada-based group of board-certified physicians specializing in private, discreet, and personalized healthcare, introduced Intravenous Vitamin Therapy (IV Therapy) to its services in Toronto and Vancouver. This addition included a novel IV hydration service featuring six variations of Vitamindrip products such as hydration, recovery, energy, cosmetics, diet and detox, and immune boost. The scientifically formulated Vitamin drip, administered intravenously, effectively addresses dehydration and various disorders such as migraines, acute muscle spasms, asthma, upper respiratory tract infections, chronic sinusitis, and seasonal allergic rhinitis.

Major players in the intravenous (IV) hydration therapy market are directing their efforts towards the development of sterile solutions, particularly CBD isolate, to meet the growing demand for CBD infusion and gain a competitive edge. CBD isolate, recognized as the purest form of cannabidiol, contains no additional cannabinoids or plant compounds. In a notable development in September 2023, Apex Labs CBD, a US-based company offering a diverse range of high-quality CBD products, launched Pico IV, a CBD isolate specifically designed for intravenous (IV) therapy. Pico IV's sterile solution ensures safe intravenous use, catering to the increasing demand for CBD infusion in the rapidly expanding IV hydration therapy market. Distinguished by the reduction of the CBD molecule size to a picometer, Pico IV offers maximum absorption and is exclusively available for online purchase to licensed IV therapy providers.

In May 2022, Fresenius Kabi AG, a prominent healthcare company based in Germany, completed the acquisition of Ivenix Inc. The financial details of the transaction were undisclosed. This strategic move by Fresenius Kabi AG is aimed at establishing a comprehensive and innovative portfolio of top-tier infusion treatment solutions specifically tailored for the American market. Ivenix Inc., based in the United States, is recognized for pioneering a new generation of intravenous (IV) hydration therapy. The acquisition aligns with Fresenius Kabi AG's commitment to enhancing and diversifying its offerings in the healthcare sector, particularly in the realm of infusion treatments.

Major companies operating in the intravenous (iv) hydration therapy market report are Revitalist, JW Life Science Corporation, NextGen Healthcare, B. Braun Medical Inc., Pfizer Inc., Fresenius Kabi AG, Liquid IV, Medtronic Plc., Drip Hydration, Amanta Healthcare Ltd., Becton Dickinson and Company, Elixir, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., Sippex IV bag, REVIV, Braun Melsungen AG, The IV Doc Inc., Terumo Medical Corporation, Grifols S.A., Harpal Clinic Ltd., Fosmo Med, Core IV Therapy LLC, Cryojuvenate UK Ltd., Hospira, Teleflex Incorporated, Sichuan Kelun Pharmaceutical Co.Ltd., ICU Medical Inc., Vygon SAS, Vifor Pharma Management AG.

North America was the largest region in the intravenous (IV) hydration therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) hydration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the intravenous (iv) hydration therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The intravenous (IV) hydration therapy market includes revenues earned by entities by providing normal saline, half-normal saline, lactated ringers, dextrose, and related detoxification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Intravenous (IV) Hydration Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on intravenous (iv) hydration therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for intravenous (iv) hydration therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intravenous (iv) hydration therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Service: Immune Boosters; Energy Boosters; Skin Care; Migraine; Other Service
  • 2) By Component: Medicated; Non-Medicated
  • 3) By End-User: Hospitals And Clinics; Wellness Centers And Spas; Home Healthcare; Other End-Users
  • Companies Mentioned: Revitalist; JW Life Science Corporation; NextGen Healthcare; B. Braun Medical Inc.; Pfizer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Intravenous (IV) Hydration Therapy Market Characteristics

3. Intravenous (IV) Hydration Therapy Market Trends And Strategies

4. Intravenous (IV) Hydration Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Intravenous (IV) Hydration Therapy Market Size and Growth

  • 5.1. Global Intravenous (IV) Hydration Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Intravenous (IV) Hydration Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Intravenous (IV) Hydration Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Intravenous (IV) Hydration Therapy Market Segmentation

  • 6.1. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immune Boosters
  • Energy Boosters
  • Skin Care
  • Migraine
  • Other Service
  • 6.2. Global Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medicated
  • Non-Medicated
  • 6.3. Global Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Wellness Centers And Spas
  • Home Healthcare
  • Other End-Users

7. Intravenous (IV) Hydration Therapy Market Regional And Country Analysis

  • 7.1. Global Intravenous (IV) Hydration Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Intravenous (IV) Hydration Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Intravenous (IV) Hydration Therapy Market

  • 8.1. Asia-Pacific Intravenous (IV) Hydration Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Intravenous (IV) Hydration Therapy Market

  • 9.1. China Intravenous (IV) Hydration Therapy Market Overview
  • 9.2. China Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Intravenous (IV) Hydration Therapy Market

  • 10.1. India Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Intravenous (IV) Hydration Therapy Market

  • 11.1. Japan Intravenous (IV) Hydration Therapy Market Overview
  • 11.2. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Intravenous (IV) Hydration Therapy Market

  • 12.1. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Intravenous (IV) Hydration Therapy Market

  • 13.1. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Intravenous (IV) Hydration Therapy Market

  • 14.1. South Korea Intravenous (IV) Hydration Therapy Market Overview
  • 14.2. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Intravenous (IV) Hydration Therapy Market

  • 15.1. Western Europe Intravenous (IV) Hydration Therapy Market Overview
  • 15.2. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Intravenous (IV) Hydration Therapy Market

  • 16.1. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Intravenous (IV) Hydration Therapy Market

  • 17.1. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Intravenous (IV) Hydration Therapy Market

  • 18.1. France Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Intravenous (IV) Hydration Therapy Market

  • 19.1. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Intravenous (IV) Hydration Therapy Market

  • 20.1. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Intravenous (IV) Hydration Therapy Market

  • 21.1. Eastern Europe Intravenous (IV) Hydration Therapy Market Overview
  • 21.2. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Intravenous (IV) Hydration Therapy Market

  • 22.1. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Intravenous (IV) Hydration Therapy Market

  • 23.1. North America Intravenous (IV) Hydration Therapy Market Overview
  • 23.2. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Intravenous (IV) Hydration Therapy Market

  • 24.1. USA Intravenous (IV) Hydration Therapy Market Overview
  • 24.2. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Intravenous (IV) Hydration Therapy Market

  • 25.1. Canada Intravenous (IV) Hydration Therapy Market Overview
  • 25.2. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Intravenous (IV) Hydration Therapy Market

  • 26.1. South America Intravenous (IV) Hydration Therapy Market Overview
  • 26.2. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Intravenous (IV) Hydration Therapy Market

  • 27.1. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Intravenous (IV) Hydration Therapy Market

  • 28.1. Middle East Intravenous (IV) Hydration Therapy Market Overview
  • 28.2. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Intravenous (IV) Hydration Therapy Market

  • 29.1. Africa Intravenous (IV) Hydration Therapy Market Overview
  • 29.2. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Intravenous (IV) Hydration Therapy Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Intravenous (IV) Hydration Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Intravenous (IV) Hydration Therapy Market Competitive Landscape
  • 30.2. Intravenous (IV) Hydration Therapy Market Company Profiles
    • 30.2.1. Revitalist
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. JW Life Science Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. NextGen Healthcare
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. B. Braun Medical Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Pfizer Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Intravenous (IV) Hydration Therapy Market Other Major And Innovative Companies

  • 31.1. Fresenius Kabi AG
  • 31.2. Liquid IV
  • 31.3. Medtronic Plc.
  • 31.4. Drip Hydration
  • 31.5. Amanta Healthcare Ltd.
  • 31.6. Becton Dickinson and Company
  • 31.7. Elixir
  • 31.8. Baxter International Inc.
  • 31.9. Otsuka Pharmaceutical Co. Ltd.
  • 31.10. Sippex IV bag
  • 31.11. REVIV
  • 31.12. Braun Melsungen AG
  • 31.13. The IV Doc Inc.
  • 31.14. Terumo Medical Corporation
  • 31.15. Grifols S.A.

32. Global Intravenous (IV) Hydration Therapy Market Competitive Benchmarking

33. Global Intravenous (IV) Hydration Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Intravenous (IV) Hydration Therapy Market

35. Intravenous (IV) Hydration Therapy Market Future Outlook and Potential Analysis

  • 35.1 Intravenous (IV) Hydration Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Intravenous (IV) Hydration Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Intravenous (IV) Hydration Therapy Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer